Form 4: Twist Bioscience SVP Sells Shares for Tax Obligations

Twist Bioscience's SVP of Human Resources, Paula Green, sold 9,724 shares of common stock to cover tax withholding obligations related to PSU vesting.

Summary

• Paula Green, SVP of Human Resources at Twist Bioscience Corp. (TWST), reported a transaction involving the company's common stock.
• The transaction occurred on October 6, 2025, and involved the disposition of 9,724 shares.
• The shares were sold at a price of $32.187 per share.
• The sale was not a discretionary trade but was mandated to cover tax withholding obligations associated with the vesting of Performance Stock Units (PSUs).
• Following this transaction, Paula Green beneficially owns 114,678 shares of Twist Bioscience common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a non-discretionary 'sell to cover' for tax purposes, which is a routine event and does not reflect a change in the insider's confidence or the company's performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ('PSUs').
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

This specific insider transaction is a routine event related to executive compensation and tax obligations, and does not inherently reflect broader industry trends or competitive positioning for Twist Bioscience.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in company fundamentals or insider sentiment.

Key Dates

Recommendation

The transaction reported is a routine 'sell to cover' to satisfy tax obligations related to PSU vesting, not a discretionary sale. As such, it does not provide new information that would warrant a change in investment recommendation based on the company's fundamentals or the insider's view of the company's prospects. Therefore, a 'hold' recommendation is appropriate, maintaining the existing investment thesis.

Keywords

Twist Bioscience, TWST, Insider Transaction, Form 4, Stock Sale, Tax Withholding, PSU Vesting, Executive Compensation